Department of Molecular Endocrinology, KMEB, University of Southern Denmark and Odense University Hospital, Odense, Denmark.
Laboratory of Molecular Physiology of Bone, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia.
Front Endocrinol (Lausanne). 2022 Sep 15;13:981487. doi: 10.3389/fendo.2022.981487. eCollection 2022.
Osteoporosis is defined as a systemic skeletal disease characterized by decreased bone mass and micro-architectural deterioration leading to increased fracture risk. Osteoporosis incidence increases with age in both post-menopausal women and aging men. Among other important contributing factors to bone fragility observed in osteoporosis, that also affect the elderly population, are metabolic disturbances observed in obesity and Type 2 Diabetes (T2D). These metabolic complications are associated with impaired bone homeostasis and a higher fracture risk. Expansion of the Bone Marrow Adipose Tissue (BMAT), at the expense of decreased bone formation, is thought to be one of the key pathogenic mechanisms underlying osteoporosis and bone fragility in obesity and T2D. Our review provides a summary of mechanisms behind increased Bone Marrow Adiposity (BMA) during aging and highlights the pre-clinical and clinical studies connecting obesity and T2D, to BMA and bone fragility in aging osteoporotic women and men.
骨质疏松症定义为一种全身性骨骼疾病,其特征是骨量减少和微结构恶化,导致骨折风险增加。在绝经后妇女和老年男性中,骨质疏松症的发病率随年龄增长而增加。在骨质疏松症中观察到的其他导致骨骼脆弱的重要因素,也影响老年人群,是肥胖和 2 型糖尿病(T2D)中观察到的代谢紊乱。这些代谢并发症与骨稳态受损和更高的骨折风险有关。骨髓脂肪组织(BMAT)的扩张,以牺牲减少的骨形成为代价,被认为是肥胖和 T2D 中骨质疏松症和骨骼脆弱的关键发病机制之一。我们的综述提供了衰老过程中骨髓脂肪增加的机制概述,并强调了将肥胖和 T2D 与 BMAT 和衰老骨质疏松症女性和男性的骨骼脆弱联系起来的临床前和临床研究。